Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Solid Biosciences Inc. | Director, 10%+ Owner | Common Stock | 4.03M | $22.3M | $5.53 | Jan 11, 2024 | Indirect |
Foghorn Therapeutics Inc. | Director | Stock Options (Right to buy) | 16K | $88.3K | $5.52 | Jun 26, 2024 | Direct |
Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $41.18 | Aug 1, 2024 | Direct |
Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $41.18 | Aug 1, 2024 | Indirect |
Aptinyx Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
Solid Biosciences Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 9.65K | Jun 6, 2023 | Direct | ||
Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 0 | Aug 1, 2024 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | Dec 28, 2021 | Direct | |
Dicerna Pharmaceuticals Inc | Director | Common Stock | 0 | $38.25 | Dec 28, 2021 | Indirect | |
Dicerna Pharmaceuticals Inc | Director | Director Stock Option (Right to Buy) | 0 | Dec 28, 2021 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | Dec 28, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CERE | Cerevel Therapeutics Holdings, Inc. | Aug 1, 2024 | 4 | $0 | 4 | Aug 5, 2024 | Director, 10%+ Owner |
FHTX | Foghorn Therapeutics Inc. | Jun 26, 2024 | 1 | $88.3K | 4 | Jun 28, 2024 | Director |
CERE | Cerevel Therapeutics Holdings, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director, 10%+ Owner |
SLDB | Solid Biosciences Inc. | Jan 11, 2024 | 1 | $5M | 4 | Jan 12, 2024 | Director, 10%+ Owner |
CERE | Cerevel Therapeutics Holdings, Inc. | Oct 16, 2023 | 1 | $125M | 4 | Oct 18, 2023 | Director, 10%+ Owner |
FHTX | Foghorn Therapeutics Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
CERE | Cerevel Therapeutics Holdings, Inc. | Jun 7, 2023 | 3 | $0 | 4 | Jun 9, 2023 | Director, 10%+ Owner |
SLDB | Solid Biosciences Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director, 10%+ Owner |
SLDB | Solid Biosciences Inc. | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director, 10%+ Owner |
SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 1 | $0 | 4 | Dec 5, 2022 | Director, 10%+ Owner |
SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 0 | $0 | 3 | Dec 5, 2022 | Director, 10%+ Owner |
FHTX | Foghorn Therapeutics Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
CERE | Cerevel Therapeutics Holdings, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director, 10%+ Owner |
APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director, 10%+ Owner |
DRNA | Dicerna Pharmaceuticals Inc | Dec 28, 2021 | 9 | -$118M | 4 | Dec 29, 2021 | Director |
FHTX | Foghorn Therapeutics Inc. | Jul 13, 2021 | 1 | $0 | 4 | Jul 14, 2021 | Director |
SLDB | Solid Biosciences Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
CERE | Cerevel Therapeutics Holdings, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director, 10%+ Owner |
DRNA | Dicerna Pharmaceuticals Inc | Jun 3, 2021 | 4 | $0 | 4 | Jun 7, 2021 | Director |
APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director, 10%+ Owner |